ARWR vs WH · rev $829.4M vs P/E 20, rev $702.0M
Arrowhead Pharmaceuticals Inc (ARWR) versus Wyndham Hotels & Resorts Inc (WH) — a side-by-side from cached financials, not a winner call.
Arrowhead Pharmaceuticals Inc (ARWR) is a biotechnology company listed on US.
Wyndham Hotels & Resorts Inc (WH) is a lodging company listed on US.
Latest reported ARWR revenue for 2025-09-30 was $829.4M. Net income was $30.1M. Revenue was up 23258.2% from 2024-09-30 to 2025-09-30. ARWR currently screens at market cap $10.59B.
Latest reported WH revenue for 2026-06-30 was $702.0M. Net income was $163.0M. WH currently screens at market cap $6.51B and trailing P/E 20.1.
ARWR currently screens at market cap $10.59B. WH currently screens at market cap $6.51B and trailing P/E 20.1.
Not investment advice. Open the ARWR and WH stock pages for the full models.
Not investment advice.